Form 4: Arteris Inc. CFO Nicholas B. Hawkins Sells Shares Under 10b5-1 Plan

Arteris Inc.'s CFO, Nicholas B. Hawkins, sold a total of 10,437 shares of common stock between December 2nd and December 4th, 2024, under a pre-arranged 10b5-1 trading plan.

Summary

• Nicholas B. Hawkins, the VP and Chief Financial Officer of Arteris, Inc., has sold shares of the company's common stock.
• The transactions occurred between December 2nd and December 4th, 2024.
• A total of 10,437 shares were sold across three separate transactions.
• The sales were executed under a pre-arranged 10b5-1 trading plan adopted on May 20, 2024.
• The weighted average sale prices ranged from $8.5583 to $8.7594 per share.
• Some shares were sold to cover tax liabilities arising from the release of restricted stock units.
• Following these transactions, Mr. Hawkins beneficially owns 184,977 shares of Arteris common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transactions were part of a pre-arranged plan and do not necessarily indicate a negative outlook on the company. However, insider sales can sometimes be perceived negatively by the market.

Positives

• The sales were conducted under a pre-arranged 10b5-1 trading plan, which is a common practice for executives to avoid accusations of insider trading.
• The plan was adopted on May 20, 2024, indicating that the sales were not based on recent non-public information.

Negatives

• The sale of shares by a high-ranking executive could be perceived negatively by some investors, potentially signaling a lack of confidence in the company's future performance.
• The sales reduced Mr. Hawkins' direct holdings in the company.

Risks

• Continued sales by insiders could put downward pressure on the stock price.
• The market may interpret these sales as a negative signal, regardless of the pre-arranged plan.

Industry Context

Insider trading activity is closely monitored in the tech industry, and these transactions are typical for executives with stock-based compensation. The use of a 10b5-1 plan is a common practice to avoid any appearance of impropriety.

Comparison to Industry Standards

• The use of 10b5-1 trading plans is a standard practice among executives at publicly traded companies, including those in the technology sector like Arteris.
• Similar sales by executives at companies like Cadence Design Systems and Synopsys are often seen, especially around vesting periods or for personal financial planning.
• The volume of shares sold is relatively small compared to the total outstanding shares of Arteris, suggesting it is not a major market event.

Stakeholder Impact

• Shareholders may react to the news of insider sales, potentially leading to short-term price fluctuations.
• Employees may be interested in the executive's stock transactions, but the pre-arranged nature of the sales should mitigate concerns.

Key Dates

Keywords

Arteris, Nicholas Hawkins, insider trading, 10b5-1 plan, stock sale, CFO, executive compensation, share transaction